Arna Immuno Ingredients Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 03-07-2024
- Paid Up Capital ₹ 0.10 M
as on 03-07-2024
- Company Age 6 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Revenue %
(FY 2023)
- Profit -18.43%
(FY 2023)
- Ebitda -18.43%
(FY 2023)
- Net Worth -1.27%
(FY 2023)
- Total Assets 19.79%
(FY 2023)
About Arna Immuno Ingredients
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Ardeshir Daruwalla and Firoze Bhathena serve as directors at the Company.
- CIN/LLPIN
U15130MH2018PTC309008
- Company No.
309008
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 May 2018
- Date of AGM
28 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Arna Immuno Ingredients?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ardeshir Daruwalla  | Director | 22-Nov-2021 | Current |
| Firoze Bhathena | Director | 07-May-2018 | Current |
Financial Performance and Corporate Structure Insights of Arna Immuno Ingredients.
Arna Immuno Ingredients Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 18.43% decrease in profit. The company's net worth dipped by a decrease of 1.27%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Arna Immuno Ingredients?
In 2023, Arna Immuno Ingredients had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Shapoorji Pallonji And Company Private LimitedActive 81 years 10 monthsFiroze Bhathena is a mutual person
- S C Finance And Investments Private LimitedActive 45 years 4 months
Firoze Bhathena is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Arna Immuno Ingredients?
Arna Immuno Ingredients has a workforce of 2 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Arna Immuno Ingredients, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Arna Immuno Ingredients's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
